HealthEquity, Inc. (NASDAQ:HQY) Holdings Decreased by Daiwa Securities Group Inc.

Daiwa Securities Group Inc. decreased its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 19.7% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 3,060 shares of the company’s stock after selling 750 shares during the quarter. Daiwa Securities Group Inc.’s holdings in HealthEquity were worth $203,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of HQY. McGlone Suttner Wealth Management Inc. acquired a new stake in HealthEquity during the fourth quarter valued at $29,000. DekaBank Deutsche Girozentrale acquired a new stake in HealthEquity during the third quarter valued at $41,000. Fifth Third Bancorp boosted its position in HealthEquity by 36.5% during the third quarter. Fifth Third Bancorp now owns 602 shares of the company’s stock valued at $44,000 after purchasing an additional 161 shares during the last quarter. Operose Advisors LLC acquired a new stake in HealthEquity during the third quarter valued at $44,000. Finally, Covestor Ltd boosted its position in HealthEquity by 92.9% during the third quarter. Covestor Ltd now owns 1,119 shares of the company’s stock valued at $82,000 after purchasing an additional 539 shares during the last quarter. Hedge funds and other institutional investors own 99.55% of the company’s stock.

HealthEquity Trading Up 1.5 %

HQY stock opened at $80.26 on Friday. HealthEquity, Inc. has a 1-year low of $48.86 and a 1-year high of $84.49. The firm has a market cap of $6.89 billion, a P/E ratio of 125.41, a P/E/G ratio of 1.29 and a beta of 0.53. The business’s 50 day moving average is $81.01 and its 200-day moving average is $74.49. The company has a current ratio of 4.76, a quick ratio of 4.76 and a debt-to-equity ratio of 0.43.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings data on Tuesday, March 19th. The company reported $0.50 earnings per share for the quarter, beating the consensus estimate of $0.42 by $0.08. HealthEquity had a return on equity of 6.91% and a net margin of 5.57%. The company had revenue of $262.39 million for the quarter, compared to analyst estimates of $258.56 million. Equities analysts anticipate that HealthEquity, Inc. will post 2.12 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

HQY has been the subject of a number of research reports. JMP Securities initiated coverage on HealthEquity in a research report on Thursday, April 4th. They set a “mkt outperform” rating and a $101.00 price objective for the company. BTIG Research boosted their price target on HealthEquity from $100.00 to $110.00 and gave the stock a “buy” rating in a research report on Wednesday, March 20th. Barrington Research reaffirmed an “outperform” rating and issued a $100.00 price target on shares of HealthEquity in a research report on Friday, March 22nd. Royal Bank of Canada boosted their price target on HealthEquity from $90.00 to $92.00 and gave the stock an “outperform” rating in a research report on Wednesday, March 20th. Finally, Bank of America boosted their price target on HealthEquity from $93.00 to $97.00 and gave the stock a “buy” rating in a research report on Wednesday, March 20th. One equities research analyst has rated the stock with a hold rating and eleven have issued a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $96.17.

Insider Buying and Selling

In related news, CEO Jon Kessler sold 33,765 shares of the stock in a transaction that occurred on Friday, March 22nd. The stock was sold at an average price of $79.81, for a total transaction of $2,694,784.65. Following the sale, the chief executive officer now directly owns 126,635 shares in the company, valued at approximately $10,106,739.35. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In other HealthEquity news, CEO Jon Kessler sold 33,765 shares of the company’s stock in a transaction on Friday, March 22nd. The stock was sold at an average price of $79.81, for a total transaction of $2,694,784.65. Following the transaction, the chief executive officer now owns 126,635 shares of the company’s stock, valued at approximately $10,106,739.35. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, EVP Delano Ladd sold 2,558 shares of the company’s stock in a transaction on Friday, March 1st. The stock was sold at an average price of $82.59, for a total value of $211,265.22. Following the transaction, the executive vice president now directly owns 47,438 shares in the company, valued at approximately $3,917,904.42. The disclosure for this sale can be found here. Insiders have sold a total of 71,322 shares of company stock worth $5,682,895 in the last three months. Insiders own 2.70% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.